News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Chevron stock has seen a 31% year-to-date increase, with a 24/7 Wall St. price target of $204.72, implying a modest 5% upside and a "hold" rating due to its current valuation. The article compares Chevron to ExxonMobil, highlighting Exxon's cheaper P/E and stronger ROE. …
Sharemaestro market context Price above Trend Line 52 weeks +16.3%Zevra Therapeutics, Inc. (ZVRA) has seen its average 12-month price target increase from $24.78 to $25.11, according to estimates from nine analysts. This updated target implies a significant 138% potential upside from the August 5 closing price, with individual forecasts ranging from $20 to …
This article provides price predictions for Chevron Corp (Dinari Tokenized Stock) (CVX) from 2026 to 2045, based on Bybit AI's analysis of user-driven Consensus Ratings and historical patterns. It forecasts a positive trend for CVX, with predicted prices reaching approximately $227.38 by 2030, $290.21 …
The Zacks Analyst Blog discusses ExxonMobil, Chevron, and BP, focusing on ExxonMobil's Q2 2026 earnings. Despite an earnings miss due to Middle East conflicts, ExxonMobil's core businesses showed strength, with non-Middle East upstream production at a two-decade high and a solid outlook supported by …
Zevra Therapeutics (NASDAQ: ZVRA) appears significantly undervalued according to GuruFocus' GF Value™, trading at $10.54, which is 54.4% below its intrinsic value estimate of $23.11. Despite strong Q2 2026 revenue growth driven by its product MIPLYFFA, the company's GF Score™ of 64/100 indicates moderate …
Zevra Therapeutics announced robust Q2 2026 earnings, reporting $39.7 million in net revenue, a 53% year-over-year increase, largely driven by $30.2 million in U.S. sales of MIPLYFFA. The company also strengthened MIPLYFFA's intellectual property with an Orange Book listing extending to 2041. Despite strong …
An investor in Chevron (CVX) has filed to sell 5,547 common shares under Rule 144, valued at approximately $1,037,265.70, through Morgan Stanley Smith Barney LLC. The sale is projected for August 5, 2026, and the shares were acquired through restricted stock vesting and open-market …
Sharemaestro market context Price above Trend Line 52 weeks +16.3%Zevra Therapeutics (ZVRA) reported strong Q2 results, with earnings of $0.25 per share significantly beating the Zacks Consensus Estimate of $0.08, and revenues of $39.66 million surpassing estimates by 22.76%. Despite this positive performance and a 17.4% year-to-date stock increase, the company currently holds …
Zevra Therapeutics, Inc. reported strong financial results for the quarter ended 2026, with revenue reaching $39.66M and diluted EPS of $0.14, primarily driven by the commercialization of MIPLYFFA. The company highlighted significant revenue growth, successful market penetration for MIPLYFFA, and ongoing progress in its …
* Zevra Therapeutics, Inc. press release [https://seekingalpha.com/pr/20608774-zevra-reports-second-quarter-2026-financial-results-and-corporate-update] (ZVRA [https://seekingalpha.com/symbol/ZVRA]): Q2 GAAP EPS of $0.14 beats by $0.03. * Revenue of $39.7M (+53.4% Y/Y) beats by $5.82M. * * Cash Position: Cash, cash equivalents and investments were $260.2 million as of June 30, 2026. Based …
Zevra Therapeutics reported strong second-quarter 2026 financial results, with $39.7 million in net revenue, a 53% increase over Q2 2025, primarily driven by MIPLYFFA sales. The company achieved a net income of $8.8 million and maintained a robust cash position of $260.2 million, which …
Just like that, cash flow matters to S&P 500 investors. And it's becoming very apparent. Shares of the nine S&P 500 stocks expected to post the most free cash flow this year, like Micron and Chevron, are smashing the rest of the market. Continue …
Zevra Therapeutics will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11, 2026, at 11:00 a.m. ET. Members of Zevra’s executive leadership team will deliver the presentation, and management will also be available for one-on-one meetings with registered conference …
Key Points Interested in Zevra Therapeutics, Inc.? Here are five stocks we like better. Revenue grew strongly: Zevra's Q2 2026 net revenue rose 53% year over year to $39.7 million, led by MIPLYFFA U.S. revenue of $30.2 million. Adjusted net income was $15.2 million, …
Chevron reported a sharp increase in Q2 2026 earnings, with net income reaching $12.1 billion, driven by record production, higher commodity prices, and contributions from acquired Hess assets. The company's sales and operating revenues rose 51% to $67.2 billion, and diluted EPS increased significantly. …
Former President Donald Trump criticized ExxonMobil and Chevron for their substantial profits, urging them to lower retail petrol prices and give back to the public. The oil companies reported combined profits of US$29 billion in the second quarter, more than triple the previous year, …
In the past week, Chevron reported second-quarter 2026 results showing revenue rising to US$70.06 billion and net income to US$12.07 billion, alongside a maintained quarterly dividend of US$1.78 per share. The earnings surge, driven by higher production, early cost reductions and war-inflated refining margins, …
Randy Sinclair, who previously led investor relations at Chevron, is moving to Northrop Grumman as VP-IR, effective August 10. This move follows Northrop Grumman's recent $3 billion deal to accelerate the production of the Patriot anti-missile system. Sinclair brings 11 years of experience from …
Northrop Grumman Corporation has appointed Randy Sinclair, formerly Chevron's investor relations head, as its new vice president of investor relations. Sinclair will report to CFO John Greene, with his appointment becoming effective on August 10.
President Donald Trump has publicly criticized ExxonMobil and Chevron for their excessive profits during the ongoing U.S.-led war against Iran. He called on the companies to reduce retail gasoline prices, arguing they are making "too much money" amid national strain. This rebuke comes as …
Integrated energy company Chevron (NYSE:CVX) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 56.3% year on year to $70.06 billion. Its non-GAAP profit of $6.06 per share was 8.8% above analysts' consensus estimates. Is now the time to buy …
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Evercore stock has delivered a strong 159.3% return over the past five years, yet the current checks send mixed valuation signals, with the …
Stephen Schork, principal and editor at The Schork Group, says refiners have virtually no ability to increase capacity and deliver more gasoline and diesel products and lower costs for consumers. President Donald Trump scolded ExxonMobil Holdings Corp. and Chevron Corp. Monday for making too …
Donald Trump criticized major oil companies Chevron and Exxon Mobil for making "too much money" due to high oil prices, urging them to reduce retail prices and give profits back to the public. He also stated that newly planned talks with Iran are its …
Zevra Therapeutics announced that its executive leadership team will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA, on Tuesday, August 11, 2026, at 11:00 a.m. ET. Management will also be available for one-on-one meetings, and a live webcast of the …
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Evercore (EVR) just delivered a fresh set of second quarter 2026 earnings and confirmed its latest dividend, while also adding veteran equity capital markets banker Dylan Tornay …
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Evercore appointed Dylan Tornay as Senior Managing Director in Equity Capital Markets. Tornay brings nearly 30 years of equity capital markets experience from Citi. …
JBH Investment Trust, associated with Chevron Corporation, plans to sell 100,000 shares of Chevron common stock on or after August 3, 2026, through J.P. Morgan Securities LLC on the NYSE. This planned sale follows two significant disposals in May 2026, where the trust sold …
Sharemaestro market context Price above Trend Line 52 weeks +16.3%Search by ticker symbol or company name and select a result to open its chart.